EVAR预后与腹主动脉瘤直径、体积及术后早期变化的关系
结果显示术前AAA直径>59 mm、体积>159 cm3及术后30天内任何直径或体积增大均与再干预及死亡显著相关。
要点
- 术前AAA直径>59 mm、体积>159 cm3与随访期再干预及死亡风险升高相关。
- 术后30天CTA显示瘤体直径或体积任何增大,均与再干预及死亡显著相关。
- 内漏相关再干预与所有分析的形态学参数均显著相关。
核心结论
- 基线AAA尺寸和体积较大及瘤囊早期重塑不良的患者,长期EVAR结局更差。
研究设计与样本
- 回顾所有患者术前及术后30天CTA图像。
- 术前最大AAA直径>59 mm、体积>159 cm3及30天CTA任何增大被视为可能影响结局的因素。
主要发现
- 平均术前与30天AAA直径分别为50.4 mm±11.8与49.1 mm±12.1,体积分别为112.9 cm3±79.5与112.1 cm3±80.5。
- 全部病例获得初次技术成功;随访34.9个月,累积再干预率12.0%,死亡率7.2%,无AAA相关死亡。
- 内漏相关再干预率为7.5%。
关键数值与推荐
- 术前AAA直径>59 mm与再干预显著相关(P=0.012),与再干预和死亡显著相关(P=0.002)。
- 术前AAA体积>159 cm3与再干预显著相关(P=0.002),与再干预和死亡显著相关(P=0.001)。
- 术后AAA直径或体积任何增大与再干预显著相关(P=0.001,P=0.001),与再干预和死亡显著相关(P=0.006,P=0.001)。
- 内漏相关再干预与所有分析的形态学参数均显著相关(P=0.019、P=0.005、P=0.005、P=0.002)。
临床怎么用
- EVAR术前可结合AAA直径与体积评估远期再干预和死亡风险。
- 术后30天CTA若见瘤体直径或体积增大,应加强随访并警惕再干预需求。
局限性
- 为双中心回顾性分析,虽数据前瞻性收集,仍可能存在选择偏倚。
- 随访时间与样本量有限,形态学阈值需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: to evaluate the impact of bi- and 3-dimensional preoperative aortic morphological features and their immediate postoperative variations on the outcome of abdominal aortic aneurysms (AAA) treated by endovascular exclusion with standard devices (EVAR). MATERIALS AND METHODS: Double centre retrospective analysis of prospectively collected registry data of EVAR patients. For all patients, preoperative and 30-day computed tomographic angiography images (CTA) were reviewed. Preoperative maximum AAA diameter >59 mm and volume >159 cm3, and any 30-day postoperative increasing at CTA, were considered as potentially influencing the outcome. The outcome measures were: primary technical success; 30-day, 1-year, and mean follow-up reintervention, all-cause and AAA-related mortality rates, and also endoleak-related reinterventions. RESULTS: Three hundred and thrity-three patients were enrolled. Mean preoperative and 30-day AAA diameter and volume were 50.4 mm ± 11.8 vs. 49.1 mm ± 12.1, and 112.9 cm3 ± 79.5 vs. 112.1 cm3 ± 80.5, respectively. Primary technical success was achieved in all cases. At 34.9 months follow-up, cumulative reintervention rate was 12.0%, mortality rates 7.2%, without AAA-related deaths. Endoleak-related reintervention rate was 7.5%. At uni- and multi-variate analysis, preoperative AAA diameter >59 mm, and AAA volume >159 cm3 were significantly associated to reintervention (P = 0.012; P = 0.002), and reintervention and death (P = 0.002; P = 0.001) during follow-up. Additionally, any increase in postoperative AAA diameter or volume was significantly associated with reintervention (P = 0.001, P = 0.001) and reintervention and death (P = 0.006, P = 0.001). Endoleak-related reintervention were also significantly associated with all of the analysed morphological parameters (P = 0.019, P = 0.005, P = 0.005, and P = 0.002, respectively). CONCLUSIONS: Patients with larger baseline AAA size and volume as well as unfavourable early remodelling of the sac are associated to worse long-term EVAR outcome.
引用
- Montelione N, Sirignano P, d'Adamo A, et al. Comparison of Outcomes Following EVAR Based on Aneurysm Diameter and Volume and Their Postoperative Variations. Ann Vasc Surg. 2021. PMID: 33549787. doi:10.1016/j.avsg.2020.12.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。